229 related articles for article (PubMed ID: 24748567)
21. Preimplantation genetic diagnosis for cancer predisposition syndromes.
Spits C; De Rycke M; Van Ranst N; Verpoest W; Lissens W; Van Steirteghem A; Liebaers I; Sermon K
Prenat Diagn; 2007 May; 27(5):447-56. PubMed ID: 17330926
[TBL] [Abstract][Full Text] [Related]
22. Preimplantation genetic diagnosis for BRCA1 exon 13 duplication mutation using linked polymorphic markers resulting in a live birth.
Jasper MJ; Liebelt J; Hussey ND
Prenat Diagn; 2008 Apr; 28(4):292-8. PubMed ID: 18302307
[TBL] [Abstract][Full Text] [Related]
23. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
Hurley K; Rubin LR; Werner-Lin A; Sagi M; Kemel Y; Stern R; Phillips A; Cholst I; Kauff N; Offit K
Cancer; 2012 Dec; 118(24):6270-7. PubMed ID: 22736296
[TBL] [Abstract][Full Text] [Related]
24. Preimplantation genetic testing for monogenic disorders: clinical experience with BRCA1 and BRCA2 from 2010-2021.
Barrett F; Shaw J; Besser AG; Grifo JA; Blakemore JK
J Assist Reprod Genet; 2023 Nov; 40(11):2705-2713. PubMed ID: 37691027
[TBL] [Abstract][Full Text] [Related]
25. High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer.
Quinn GP; Vadaparampil ST; Miree CA; Lee JH; Zhao X; Friedman S; Yi S; Mayer J
Hum Reprod; 2010 Oct; 25(10):2543-50. PubMed ID: 20713415
[TBL] [Abstract][Full Text] [Related]
26. [Preimplantation genetic diagnosis (PGD) for cancer predisposition syndromes].
Malcov M; Ben-Yosef D; Amit A; Yaron Y
Harefuah; 2011 Jun; 150(6):496-501, 553. PubMed ID: 21800485
[TBL] [Abstract][Full Text] [Related]
27. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
Lipton JH; Zargar M; Warner E; Greenblatt EE; Lee E; Chan KKW; Wong WWL
Hum Reprod; 2020 Feb; 35(2):434-445. PubMed ID: 32099994
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of trophectoderm biopsy on cryopreserved blastocysts: a case series.
Lathi RB; Massie JA; Gilani M; Milki AA; Westphal LM; Baker VL; Behr B
Reprod Biomed Online; 2012 Nov; 25(5):504-7. PubMed ID: 22985500
[TBL] [Abstract][Full Text] [Related]
29. BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
Julian-Reynier C; Fabre R; Coupier I; Stoppa-Lyonnet D; Lasset C; Caron O; Mouret-Fourme E; Berthet P; Faivre L; Frenay M; Gesta P; Gladieff L; Bouhnik AD; Protière C; Noguès C
Genet Med; 2012 May; 14(5):527-34. PubMed ID: 22241105
[TBL] [Abstract][Full Text] [Related]
30. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
31. [The clinical study of familial breast cancer - now and the problems].
Nomizu T; Matsuzaki M; Katagata N; Watanabe F; Akama Y
Gan To Kagaku Ryoho; 2012 Apr; 39(4):502-5. PubMed ID: 22504672
[TBL] [Abstract][Full Text] [Related]
32. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
[TBL] [Abstract][Full Text] [Related]
33. Cumulative reproductive outcome after preimplantation genetic diagnosis: a report on 1498 couples.
Verpoest W; Haentjens P; De Rycke M; Staessen C; Sermon K; Bonduelle M; Devroey P; Liebaers I
Hum Reprod; 2009 Nov; 24(11):2951-9. PubMed ID: 19654112
[TBL] [Abstract][Full Text] [Related]
34. [Results from 10 years of preimplantation-genetic diagnostics in The Netherlands].
de Die-Smulders CE; Land JA; Dreesen JC; Coonen E; Evers JL; Geraedts JP
Ned Tijdschr Geneeskd; 2004 Dec; 148(50):2491-6. PubMed ID: 15638197
[TBL] [Abstract][Full Text] [Related]
35. BRCA1/2 and clinical outcome in a monoinstitutional cohort of women with hereditary breast cancer.
Sambiasi D; Lambo R; Pilato B; Tommasi S; Trojano G; Kardhashi A; Digennaro M; Trojano V; Simone G; Paradiso A
Oncol Rep; 2014 Jan; 31(1):365-9. PubMed ID: 24145998
[TBL] [Abstract][Full Text] [Related]
36. [Present status and tasks for genetic testing and risk-reducing surgery in patients with hereditary breast and ovarian cancer].
Arai M; Taki K; Iwase H; Takizawa K; Nishimura S; Iwase T
Gan To Kagaku Ryoho; 2012 Apr; 39(4):525-31. PubMed ID: 22504676
[TBL] [Abstract][Full Text] [Related]
37. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.
Woodson AH; Muse KI; Lin H; Jackson M; Mattair DN; Schover L; Woodard T; McKenzie L; Theriault RL; Hortobágyi GN; Arun B; Peterson SK; Profato J; Litton JK
Oncologist; 2014 Aug; 19(8):797-804. PubMed ID: 24951607
[TBL] [Abstract][Full Text] [Related]
39. Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.
Ormondroyd E; Donnelly L; Moynihan C; Savona C; Bancroft E; Evans DG; Eeles R; Lavery S; Watson M
Eur J Hum Genet; 2012 Jan; 20(1):4-10. PubMed ID: 21811309
[TBL] [Abstract][Full Text] [Related]
40. Attitude of BRCA1/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing for primary prevention of breast and ovarian cancer in the next generation.
Nahshon C; Lavie O; Oron G
J Assist Reprod Genet; 2023 Dec; 40(12):2835-2842. PubMed ID: 37751121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
